Urticarial vasculitis and infection due to Mycoplasma pneumoniae [5];Vasculitis urticariforme e infección por Mycoplasma pneumoniae

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 21, Issue 4, 2003, Pages 218-219

  Jover, Francisco ^a   Cuadrado, José María ^a   Ivars, Joaquín ^a   Merino, Jaime ^a  

^a HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ANTIMALARIAL AGENT; DAPSONE; FLUOXETINE; TETRACYCLINE;

ADULT; BACTERIAL INFECTION; CASE REPORT; CLINICAL FEATURE; HUMAN; LETTER; LEUKOCYTOCLASTIC VASCULITIS; MYCOPLASMA PNEUMONIAE; PATHOPHYSIOLOGY; PNEUMONIA; SKIN BIOPSY; URTICARIA; VASCULITIS;

EID: 0345382515     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13045459     Document Type: Letter

References (8)

1. Mehregan DR, Gibson LE. Pathophysiology of urticarial vasculitis. Arch Dermatol 1998,134:88-9.
2. Wisnieski JJ. Urticarial vasculitis. Curr Op Rheumatol 2000;12:24-31.
3. Kuniyuki S, Katoh H. Urticarial vasculitis with papular lesions in a patient with type C hepatitis and cryoglobulinemia. J Dermatol 1996;23:279-83.
4. Matteson EL. Interferon 2-alfa therapy for urticarial vasculitis with angioedema apparently following hepatitis A infection. J Rheumatol 1996;23:382-4.
5. Wards JR, Persoto JL, Isselbacher KJ. Circulating immune complexes and complement sequence activation in infectious mononucleosis. Am J Med 1976;60:269-72.
6. Olson JC, Esterly NB. Urticarial vasculitis and Lyme disease. J Am Acad Dermatol 1990;22:1114-6.
7. Davis MD, Daoud MS, Kirby B, Gibson LE, Rogers RS. III: Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis. J Am Acad Dermatol 1998;38:899-905.
8. Lucier TS, Heitzman K, Liu SK, Hu PG. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob Agents Chemother 1995;39:2770-3.